GFAP and Alzheimer disease: Tukey’s post hoc tests indicated that the levels of GFAP (p < 0.001; Figure 3B) and CD68 (p = 0.003; Figure 3C) in the prefrontal cortex were significantly increased in the 3 × Tg-AD control group compared to the non-Tg control group.